Nitrous Oxide Versus Intravenous Sedation for Anesthesia (NOVIA)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 173364
- University of Colorado
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131
- University of New Mexico Health Sciences Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years old or older
- pregnancy termination at gestational age of 12-16 weeks
- able to read and understand either English or Spanish
- able to obtain reliable post-procedure transportation
Exclusion Criteria:
- contraindications to outpatient pregnancy termination
- contraindications to nitrous oxide use (such as pernicious anemia, current treatment with bleomycin chemotherapy, active upper respiratory illness, or COPD)
- intrauterine fetal demise
- chronic narcotic use
- known adverse reaction to nitrous oxide, Fentanyl, or Versed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Nitrous oxide and IV saline
Participants in the nitrous oxide group will receive a scented face mask through which nitrous oxide will be administered.
The nitrous content of the gas will be titrated up by 20% every 5 breaths with a goal of 70% N2O/ 30% O2 as tolerated by the participant.
This group will also receive saline through an IV.
All participants will receive local anesthesia in the form of a paracervical block and ibuprofen pre-operatively.
|
Participants in the nitrous oxide group will receive a scented face mask through which nitrous oxide will be administered.
The nitrous content of the gas will be titrated up by 20% every 5 breaths with a goal of 70% N2O/ 30% O2 as tolerated by the participant.
This group will also receive saline through an IV.
All participants will receive local anesthesia in the form of a paracervical block and ibuprofen pre-operatively.
|
|
NO_INTERVENTION: Standard Care (IV Sedation and Oxygen)
Within the IV sedation group, women will receive 100mcg fentanyl and 2mg midazolam at least two minutes prior to initiation of the procedure.
This group will also receive 100% oxygen by a scented face mask.
All participants will receive local anesthesia in the form of a paracervical block and ibuprofen pre-operatively.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale (VAS) Score for Maximum Procedural Pain
Time Frame: Assessed immediately following completion of the procedure (as defined as removal of the speculum)
|
To compare women's maximum procedural pain measured on a visual analog scale (VAS) during a surgical abortion between 12 weeks 0 days to 16 weeks 0 days gestational age between women randomized to nitrous oxide versus intravenous sedation.
A score of 0 represents no pain and a score of 100 represents pain as bad as it could be.
|
Assessed immediately following completion of the procedure (as defined as removal of the speculum)
|
|
Satisfaction With Anesthesia (Iowa Satisfaction With Anesthesia Scale [ISAS])
Time Frame: Assessed 30 minutes after procedure completion.
|
The Iowa Satisfaction with Anesthesia Scale (ISAS) was given to women following a surgical abortion.
The ISAS score is the mean of 11 responses to questions regarding satisfaction with anesthesia and has a score range of -3 (disagree strongly) to 3 (agree strongly).
|
Assessed 30 minutes after procedure completion.
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- UNMHSC 16-101
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.